Advancing Claude in healthcare and the life sciences

In October, we announced Claude for Life Sciences , our latest step in making Claude a productive research partner for scientists and clinicians, and in helping Claude to support those in industry bringing new scientific advancements to the public.

Now, we’re expanding that feature set in two ways. First, we’re introducing Claude for Healthcare , a complementary set of tools and resources that allow healthcare providers, payers, and health tech companies and startups to use Claude for medical purposes through HIPAA-ready products. We're also introducing tools to help individuals understand and navigate their personal health data. Second, we’re adding new capabilities for life sciences: connecting Claude to more scientific platforms, and helping it provide greater support in areas ranging from clinical trial management to regulatory operations.

These features build on top of major recent improvements we’ve made to Claude’s general intelligence. These improvements are best captured by evaluations of Claude’s agentic performance on detailed simulations of medical and scientific tasks, since this correlates most closely to real-world usefulness. Here, Claude Opus 4.5, our latest model, represents a major forward step:

Carta Healthcare's implementation of Anthropic models via Amazon Bedrock has allowed for rapid and secure deployment of the newest models. Unlocking our hybrid intelligence AI system that is turning into a complete re-invention of understanding a patient’s medical record for clinical data abstraction.

With these model improvements and our new tools, Claude is now dramatically more useful for real-world healthcare and life sciences tasks. Ultimately, it’s those real-world outcomes that have motivated our work: these tools can be used to speed up prior authorization requests so that patients can get life saving care more quickly, can help with patient care coordination to reduce the pressures on clinicians' time, and help with regulatory submissions so that more life saving drugs can come to market faster. We discuss the practical ways that Claude can be used across these industries in more detail below.

With these new tools, Claude can provide meaningful support for healthcare startups building new products, and for large enterprises looking to integrate AI more deeply into their operations. For example, Claude can:

Support claims appeals . Denied claims cost time and money for all parties. By pulling together the necessary information from patient records, coverage policies, clinical guidelines and prior documentation, Claude helps providers build stronger appeals, and helps payers to process them more quickly.

Coordinate care and triage patient messages. Claude can support care teams in navigating a large volume of patient portal messages, referrals, and handoffs. It can sort through these to identify what needs immediate attention, and to ensure that nothing gets inadvertently forgotten.

In addition, Opus 4.5 with extended thinking improves on earlier Claude models in producing correct answers on our suite of honesty evaluations, reflecting the progress we’ve made on factual hallucinations. 1

Connectors are tools that allow users to give Claude access to other platforms directly. For payers and providers, we’ve added several connectors that make healthcare information easier to find, access, and understand. These allow Claude to pull information from industry-standard systems and databases, meaning that clinicians and administrators can save significant time finding the data and generating the reports they need.

Since HIPAA-compliant organizations can now use Claude for Enterprise, they can also access existing healthcare-related connectors, including PubMed , which provides access to more than 35 million pieces of biomedical literature and allows Claude to quickly surface the latest research, and produce up-to-date literature reviews.